Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    UC Davis Develops New Latent TB Testing Method

    By Global Biodefense StaffMay 24, 2012
    Share
    Facebook LinkedIn Reddit Email

    Engineers at UC Davis have developed a microfluidic chip to test for latent tuberculosis (TB) which aims to be more reliable, faster and less expensive than current testing options available.

    According to the Centers for Disease Control and Prevention, an estimated 1.5 million people worldwide are killed by the disease annually, and nearly one-third of the world’s population is infected with latent TB.  Those with latent TB are at risk for the tuberculosis bacteria to become active if their immune system is compromised.

    Current tests for latent TB are based on detecting interferon-gamma, a disease-fighting chemical made by cells of the immune system.  The researchers at UC Davis took a novel approach to detection utilizing a gold wafer coated with short pieces of single-strand DNA segments known to “stick” specifically to interferon-gamma. Then using a chip that has tiny channels for blood samples, they mounted the wafer. If interferon-gamma is in a blood sample, it sticks to the DNA, prompting an electrical signal that can be read by a clinician. High interferon-gamma levels would be correlated to diagnose latent TB.

    Such a device would allow rapid results and circumvent the need to send samples out to a laboratory. “Our assay is cheaper, reusable, and gives results in real time,” said Ying Liu, a UC Davis Department of Biomedical Engineering research specialist working with Professor Alexander Revzin on the project.

    The researchers have filed a patent application for the technology. Moving forward, the team plans to incorporate the microfluidic sensor and electronic readout onto a single chip and then work towards FDA approval and commercialization of the diagnostic device.

    Image provided courtesy of Ying Liu, UC Davis

    Chemical Detection Tuberculosis
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleCBRNE CLS Industry Day Announced
    Next Article DoD to Fund Development of Food Pathogen Tests for JBAIDS Biodetector

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023

    Field Detection of Botulinum Neurotoxin with Acoustic Wave Sensors

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.